Michelle Eldred’s daughter, Amelia, was diagnosed with bone cancer in 2017 on her seventh birthday. Here, Michelle tells us about a pioneering procedure which helped Amelia remain active after a leg amputation.
Gareth Veal, Professor of Cancer Pharmacology at the Newcastle University Cancer Centre, leads a team helping doctors to personalise treatments through an innovative process called ‘therapeutic drug monitoring’. Here, he tells us more about his work.
Single-cell transcriptomics linked to lineage tracing to interrogate the role of intra-tumour heterogeneity in shaping therapeutic susceptibility and resistance in paediatric cancer
Caroline Brown, Lead Complementary Therapist for Paediatrics, Teenagers and Young Adults at The Royal Marsden Hospital
Artificial intelligence (AI) has helped scientists propose a promising new drug combination for DIPG brain tumours. Prof Chris Jones, Director of the Brain Tumour Research Centre of Excellence at the Institute of Cancer Research (ICR), and Dr Fernando Carceller, Paediatric Neuro-Oncology Consultant at The Royal Marsden Hospital, tell us more.
The Little Princess Trust (LPT) has announced 10 new research projects that will improve outcomes for children with cancer, awarded in partnership with Children’s Cancer and Leukaemia Group (CCLG).
In the UK and Ireland, over 100 childhood cancer researchers have been funded through CCLG. But what are they working on? Let's take a trip to the University of Oxford to find out...
The idea that everyone should be treated equally is great in principle – but is it enough? We look at the difference between equity and equality to see how it can affect young patients.
Wilf was diagnosed with stage 4 Wilms tumour in 2022 when he was six years old. His mother, Tori, shares his story.
